Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix.
Jesinghaus M, Strehl J, Boxberg M, Brühl F, Wenzel A, Konukiewitz B, Schlitter AM, Steiger K, Warth A, Schnelzer A, Kiechle M, Beckmann MW, Noske A, Hartmann A, Mehlhorn G, Koch MC, Weichert W. Jesinghaus M, et al. Among authors: noske a. J Pathol Clin Res. 2018 Apr;4(2):93-102. doi: 10.1002/cjp2.95. Epub 2018 Mar 8. J Pathol Clin Res. 2018. PMID: 29665323 Free PMC article.
Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive study.
Noske A, Möbus V, Weber K, Schmatloch S, Weichert W, Köhne CH, Solbach C, Ingold Heppner B, Steiger K, Müller V, Fasching P, Karn T, van Mackelenbergh M, Marmé F, Schmitt WD, Schem C, Stickeler E, Loibl S, Denkert C. Noske A, et al. Eur J Cancer. 2019 Jun;114:76-88. doi: 10.1016/j.ejca.2019.04.010. Epub 2019 May 7. Eur J Cancer. 2019. PMID: 31075727 Clinical Trial.
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Noske A, Ammann JU, Wagner DC, Denkert C, Lebeau A, Sinn P, Kreipe HH, Sommer U, Baretton G, Steiger K, Kiechle M, Hieke-Schulz S, Flores M, Roth W, Weichert W. Noske A, et al. Histopathology. 2021 Mar;78(4):567-577. doi: 10.1111/his.14254. Epub 2020 Nov 27. Histopathology. 2021. PMID: 32936950
The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations.
Willvonseder B, Stögbauer F, Steiger K, Jesinghaus M, Kuhn PH, Brambs C, Engel J, Bronger H, Schmidt GP, Haller B, Weichert W, Keller G, Noske A, Pfarr N, Boxberg M. Willvonseder B, et al. Among authors: noske a. Cancer Immunol Immunother. 2021 Jun;70(6):1679-1689. doi: 10.1007/s00262-020-02813-3. Epub 2020 Dec 19. Cancer Immunol Immunother. 2021. PMID: 33340331 Free PMC article.
Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer.
Klein E, Kiechle M, Josipovic A, Anders SI, Noske A, Mogler C, Hapfelmeier A, Ettl J. Klein E, et al. Among authors: noske a. Breast Cancer Res Treat. 2024 Aug;207(1):119-127. doi: 10.1007/s10549-024-07346-2. Epub 2024 May 9. Breast Cancer Res Treat. 2024. PMID: 38722442 Free PMC article.
108 results